Biologics Research Review, Issue 19

In this issue:

Indicators of rituximab infusion-related reactions
Nivolumab for newly-diagnosed Hodgkin lymphoma
Iodine-131 tositumomab + chemotherapy in untreated MCL
EPOCH-R vs R-CHOP in DLBCL
CheckMate 436: nivolumab + brentuximab vedotin for R/R PMBL
IPH4102: a new monoclonal antibody for R/R CTCL
Long-term results of the PRIMA study
Polatuzumab vedotin in untreated DLBCL
Inotuzumab ozogamicin for ALL
Obinutuzumab + ibrutinib induction therapy in CLL

Please login below to download this issue (PDF)

Subscribe